Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double-blind, randomized, placebo-controlled, dose-ranging trial

Robert Croop, Jennifer Madonia, David A. Stock, Alexandra Thiry, Micaela Forshaw, Abigail Murphy, Vladimir Coric, Richard B. Lipton

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double-blind, randomized, placebo-controlled, dose-ranging trial'. Together they form a unique fingerprint.

Medicine & Life Sciences